The Thalion Initiative conducts collaborative research with world-leading experts in geroscience into age-related conditions and diseases. Our work explores novel approaches in comparative biology, synthetic biology, embryonic rejuvenation and artificial intelligence (AI) to improve health outcomes and enhance therapeutic options.
By integrating insights from evolutionary biology and engineering disciplines, we aim to design more effective interventions that extend healthspan and increase drug development efficiency.
OUR VISION
The Thalion Initiative is more than a research endeavor; it is a movement to transform how we understand and approach medicine. By integrating cutting-edge geroscience with interdisciplinary collaboration, we are paving the way for a future where age-related diseases are not only treatable but preventable, and where healthspan and lifespan can be extended to unprecedented levels.
OUR GOALS
Overcoming Biomedical Stagnation
Addressing gaps in understanding aging biology mechanisms to improve drug predictability and therapeutic design.
Exploring the Fundamentals of Aging
Using first-principles approaches to uncover core mechanisms of aging and develop systemic interventions.
Developing Transformative Tools and Therapies
Building advanced measurement and modeling tools for groundbreaking discoveries.
